TSBX — Turnstone Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual balance sheet for Turnstone Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	161	82.1	94.8
Net Total Accounts Receivable
Net Total Receivables	6.71	8.73	0.194
Prepaid Expenses
Total Other Current Assets
Total Current Assets	177	98	103
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.37	14.4	9.12
Other Long Term Assets
Total Assets	187	115	113
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	55	34.8	12
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	97.3	44.5	14.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	89.9	70.5	98.7
Total Liabilities & Shareholders' Equity	187	115	113
Total Common Shares Outstanding